The Effect of Nurse Navigators in Digital Remote Monitoring in Cancer Care: Case Study Using Structural Equation Modeling
- PMID: 40153795
- PMCID: PMC11992497
- DOI: 10.2196/66275
The Effect of Nurse Navigators in Digital Remote Monitoring in Cancer Care: Case Study Using Structural Equation Modeling
Abstract
Background: The purpose of digital remote monitoring (DRM) is improving cancer care management. However, its effectiveness largely depends on the role of nurse navigators (NNs) within these systems to process data and lead action.
Objective: This study aims to fill gaps in our understanding of the role of NNs within a specific system, drawing on the Cancérologie parcours région Ile-de-France (CAPRI) DRM program applied to oncology patients.
Methods: The CAPRI DRM, targeting patients taking oral anticancer agents, combines digital interfaces with NN interventions. A phase 3 randomized controlled trial involving 559 patients assessed its safety and efficacy, with the primary end point being the relative dose intensity. This report focuses on patients in the CAPRI arm, evaluating the impact of NN interventions on outcomes such as toxicity, hospitalization, and emergency visits. Data on patient characteristics, NN interventions, and patient satisfaction surveys were analyzed using structural equation modeling.
Results: The study included 187 patients. Patient characteristics were significantly correlated with outcomes. Across all the models we used, the quality of NN interventions was consistently associated with higher patient satisfaction, with correlation coefficients ranging from 0.332 (95% CI 0.154-0.510; P<.001) to 0.366 (95% CI 0.182-0.550; P<.001). The number of grade ≥3 toxicity events correlated positively with NN referrals to oncologists. Hospitalization length was positively related to NN referral (coefficient 0.102, 95% CI 0.051-0.153; P<.001) and inversely to NN advice (coefficient -0.045, 95% CI -0.096 to 0.006; P=.08). Emergency visits showed a negative correlation with NN actions (coefficient -0.478, 95% CI -0.923 to 0.033; P=.04) and a positive correlation with NN calls and referrals (coefficient 0.516, 95% CI 0.069-0.963; P=.02).
Conclusions: This study shows the central role of NNs in making DRM effective. Despite the study's limitations, these results support the design of DRM as a hybrid model of automated digital tools and human support. Future research should explore the applicability of such a DRM model in various clinical settings to clarify the optimal association between automated systems and NN expertise.
Trial registration: ClinicalTrials.gov NCT02828462; https://www.clinicaltrials.gov/study/NCT02828462.
Keywords: digital remote monitoring; hospitalization; nurse navigators; oncology; patient care; patient satisfaction; toxicity.
©Etienne Minvielle, Joel Perez-Torrents, Israa Salma, Philippe Aegerter, Marie Ferrua, Charles Ferté, Henri Leleu, Delphine Mathivon, Claude Sicotte, Mario Di Palma, Florian Scotté. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 28.03.2025.
Conflict of interest statement
Conflicts of Interest: CF is a full-time employee of Resilience Care. FS declares conflicts related to BMS, Pfizer, Sanofi, Roche, MSD, Leo Pharma, AMGEN, Pierre Fabre Oncologie, Gilead, Pharmanovia, Daiichi Sankyo, Thermo Fisher, Viatris, and GSK. After this study, Resilience Care derived a commercial solution from Cancérologie parcours région Ile-de-France (CAPRI). However, Resilience Care was not involved in the study design or analysis.
Figures
References
-
- Using remote patient monitoring technologies for better cardiovascular disease outcomes. American Heart Association. 2019. [2024-10-24]. https://www.heart.org/-/media/files/about-us/policy-research/policy-posi... .
-
- Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016 Feb 20;34(6):557–65. doi: 10.1200/JCO.2015.63.0830. https://europepmc.org/abstract/MED/26644527 JCO.2015.63.0830 - DOI - PMC - PubMed
-
- Maguire R, McCann L, Kotronoulas G, Kearney N, Ream E, Armes J, Patiraki E, Furlong E, Fox P, Gaiger A, McCrone P, Berg G, Miaskowski C, Cardone A, Orr D, Flowerday A, Katsaragakis S, Darley A, Lubowitzki S, Harris J, Skene S, Miller M, Moore M, Lewis L, DeSouza N, Donnan PT. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) BMJ. 2021 Jul 21;374:n1647. doi: 10.1136/bmj.n1647. https://www.bmj.com/lookup/pmidlookup?view=long&pmid=34289996 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
